In patients with deficiency porphyria (ADP), erythrocyte aminolevulinic acid (ALA) dehydratase (ALAD) activity is typically reduced by 80%, or more, from normal levels.
ALAD activity can be inhibited in other situations including hereditary tyrosinemia type 1, lead intoxication, and exposure to styrene, trichloroethylene, and bromobenzene. These causes should be ruled out when considering a diagnosis of ADP.